+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Cardiovascular Information System Market Size, Share & Industry Trends Analysis Report By Type (CVIS, and CPACS), By Mode Of Operation (Web-based, Cloud-based, and On-site), By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • October 2023
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5935925
The Asia Pacific Cardiovascular Information System Market would witness market growth of 10.9% CAGR during the forecast period (2023-2030).

The demographic shift towards an aging population contributes to cardiovascular disease prevalence. As the population ages, there is a natural increase in heart-related issues. Thus, healthcare providers require sophisticated systems like CVIS to effectively manage the growing demand for cardiovascular services. These systems are instrumental in ensuring that patient data, test results, and diagnostic information are accessible, secure, and well-organized.

The role of CVIS extends beyond clinical applications; it encompasses administrative and billing functions. Some CVIS solutions include features that help healthcare facilities manage the financial aspects related to cardiovascular services. Billing, insurance claims, and reimbursement processes can be streamlined through these systems, reducing administrative burdens and ensuring healthcare providers receive appropriate compensation for their services.

Many countries in the Asia-Pacific region are experiencing demographic transitions with aging populations. According to the United Nations Population Fund, 1 in 4 people in Asia Pacific will be older than 60 by 2050. Between 2010 and 2050, the region's older population (those over 60) will triple, growing to almost 1.3 billion. Older individuals are at higher risk of CVD, and the increased longevity in the region contributes to a higher prevalence of heart diseases. Therefore, because of the higher prevalence of CVD and a significant aging population, the demand for modern healthcare solutions will increase in the region. As a result, the region will present lucrative growth prospects for the market.

The China market dominated the Asia Pacific Cardiovascular Information System Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $161.9 Million by 2030. The Japan market is registering a CAGR of 10.2% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 11.6% during (2023 - 2030).

Based on Type, the market is segmented into CVIS, and CPACS. Based on Mode Of Operation, the market is segmented into Web-based, Cloud-based, and On-site. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., GE HealthCare Technologies, Inc., Cisco Systems, Inc., Fujifilm Holdings Corporation, Siemens Healthineers AG (Siemens AG), Cerner Corporation (Oracle Corporation), Lumedx Corporation (Intelerad Medical Systems Incorporated), Agfa-Gevaert Group, Honeywell International, Inc., and McKesson Corporation

Scope of the Study

Market Segments Covered in the Report:

By Type
  • CVIS
  • CPACS
By Mode Of Operation
  • Web-based
  • Cloud-based
  • On-site
By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:


  • Koninklijke Philips N.V.
  • GE HealthCare Technologies, Inc.
  • Cisco Systems, Inc.
  • Fujifilm Holdings Corporation
  • Siemens Healthineers AG (Siemens AG)
  • Cerner Corporation (Oracle Corporation)
  • Lumedx Corporation (Intelerad Medical Systems Incorporated)
  • Agfa-Gevaert Group
  • Honeywell International, Inc.
  • McKesson Corporation

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Cardiovascular Information System Market, by Type
1.4.2 Asia Pacific Cardiovascular Information System Market, by Mode Of Operation
1.4.3 Asia Pacific Cardiovascular Information System Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2022
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.4.2 Key Strategic Move: (Mergers & Acquisition: 2020, Aug - 2023, Feb) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. Asia Pacific Cardiovascular Information System Market, by Type
5.1 Asia Pacific CVIS Market, by Country
5.2 Asia Pacific CPACS Market, by Country
Chapter 6. Asia Pacific Cardiovascular Information System Market, by Mode Of Operation
6.1 Asia Pacific Web-based Market, by Country
6.2 Asia Pacific Cloud-based Market, by Country
6.3 Asia Pacific On-site Market, by Country
Chapter 7. Asia Pacific Cardiovascular Information System Market, by Country
7.1 China Cardiovascular Information System Market
7.1.1 China Cardiovascular Information System Market, by Type
7.1.2 China Cardiovascular Information System Market, by Mode Of Operation
7.2 Japan Cardiovascular Information System Market
7.2.1 Japan Cardiovascular Information System Market, by Type
7.2.2 Japan Cardiovascular Information System Market, by Mode Of Operation
7.3 India Cardiovascular Information System Market
7.3.1 India Cardiovascular Information System Market, by Type
7.3.2 India Cardiovascular Information System Market, by Mode Of Operation
7.4 South Korea Cardiovascular Information System Market
7.4.1 South Korea Cardiovascular Information System Market, by Type
7.4.2 South Korea Cardiovascular Information System Market, by Mode Of Operation
7.5 Singapore Cardiovascular Information System Market
7.5.1 Singapore Cardiovascular Information System Market, by Type
7.5.2 Singapore Cardiovascular Information System Market, by Mode Of Operation
7.6 Malaysia Cardiovascular Information System Market
7.6.1 Malaysia Cardiovascular Information System Market, by Type
7.6.2 Malaysia Cardiovascular Information System Market, by Mode Of Operation
7.7 Rest of Asia Pacific Cardiovascular Information System Market
7.7.1 Rest of Asia Pacific Cardiovascular Information System Market, by Type
7.7.2 Rest of Asia Pacific Cardiovascular Information System Market, by Mode Of Operation
Chapter 8. Company Profiles
8.1 Koninklijke Philips N.V.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 GE HealthCare Technologies, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 Cisco Systems, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 Fujifilm Holdings Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 SWOT Analysis
8.5 Siemens Healthineers AG (Siemens AG)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Acquisition and Mergers:
8.5.6 SWOT Analysis
8.6 Oracle Corporation (Cerner Corporation)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Intelerad Medical Systems Incorporated (Lumedx Corporation)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.7.3 SWOT Analysis
8.8 Agfa-Gevaert Group
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 SWOT Analysis
8.9 Honeywell International, Inc.
8.9.1 Company Overview
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Product Launches and Product Expansions:
8.9.6 SWOT Analysis
8.10. McKesson Corporation
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental Analysis
8.10.4 Research & Development Expense
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Acquisition and Mergers:
8.10.6 SWOT Analysis

Companies Mentioned

  • Koninklijke Philips N.V.
  • GE HealthCare Technologies, Inc.
  • Cisco Systems, Inc.
  • Fujifilm Holdings Corporation
  • Siemens Healthineers AG (Siemens AG)
  • Cerner Corporation (Oracle Corporation)
  • Lumedx Corporation (Intelerad Medical Systems Incorporated)
  • Agfa-Gevaert Group
  • Honeywell International, Inc.
  • McKesson Corporation

Methodology

Loading
LOADING...